RxSight, Inc. expected to post a loss of 33 cents a share - Earnings Preview

RxSight

04/08/2026 24:19

RxSight, Inc. RXST.OQ RXST.O is expected to  show a fall in quarterly revenue when it reports  results on August 5 for the period ending June 30 2026
The Aliso Viejo California-based  company is expected to report a 3.2% decrease in revenue to $32.547 million from $33.64 million a year ago, according to the mean estimate from 10 analysts, based on LSEG data.
​LSEG's mean analyst estimate for RxSight, Inc. is for a loss of 33 cents per share. 
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 7 "hold" and 2 "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for RxSight, Inc. is $8.00, about 27.2% above its last closing price of $6.29
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.29
-0.28
-0.38
Missed
-35
Dec. 31 2026
-0.33
-0.33
-0.22
Beat
33.8
Sep. 30 2025
-0.37
-0.38
-0.24
Beat
36.6​
Jun. 30 2025
-0.26
-0.24
-0.29
Missed
-19
​​Mar. 31 2025
-0.22
-0.22
-0.20
Beat
7.4
Dec. 31 2024
-0.16
-0.17
-0.15
Beat
9.3​
Sep. 30 2024
-0.24
-0.25
-0.16
Beat
35
Jun. 30 2024
-0.22
-0.22
-0.16
Beat
28.4
This summary was machine generated August 3 at 23:19 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)